Nant Capital, Llc - Net Worth and Insider Trading
Nant Capital, Llc Net Worth
The estimated net worth of Nant Capital, Llc is at least $93,158 dollars as of 2024-05-02. Nant Capital, Llc is the 10% Owner of Heliogen Inc and owns about 67,020 shares of Heliogen Inc (HLGN) stock worth over $93,158. Details can be seen in Nant Capital, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nant Capital, Llc has not made any transactions after 2024-02-15 and currently still holds the listed stock(s).
Transaction Summary of Nant Capital, Llc
Nant Capital, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nant Capital, Llc owns 6 companies in total, including Benitec Biopharma Inc (BNTC) , Tribune Publishing Co (TPCO) , and NantHealth Inc (NHIQ) among others .
Click here to see the complete history of Nant Capital, Llc’s form 4 insider trades.
Insider Ownership Summary of Nant Capital, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BNTC | Benitec Biopharma Inc | 2020-04-15 | 10 percent owner |
| TPCO | Tribune Publishing Co | 2016-06-01 | 10 percent owner |
| NHIQ | NantHealth Inc | 2021-04-27 | 10 percent owner |
 | | 2024-02-15 | 10 percent owner |
| | 2021-12-30 | 10 percent owner |
| | 2023-09-11 | 10 percent owner |
Nant Capital, Llc Latest Holdings Summary
Nant Capital, Llc currently owns a total of 1 stock. Nant Capital, Llc owns 67,020 shares of Heliogen Inc (HLGN) as of February 15, 2024, with a value of $93,158.
Latest Holdings of Nant Capital, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HLGN | Heliogen Inc | 2024-02-15 | 67,020 | 1.39 | 93,158 |
Holding Weightings of Nant Capital, Llc
Nant Capital, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Nant Capital, Llc has made a total of 11 transactions in Heliogen Inc (HLGN) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Heliogen Inc is the acquisition of 442,298 shares on February 15, 2024, which cost Nant Capital, Llc around $672,293.
Insider Trading History of Nant Capital, Llc
- 1
Nant Capital, Llc Trading Performance
GuruFocus tracks the stock performance after each of Nant Capital, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nant Capital, Llc is -31.58%. GuruFocus also compares Nant Capital, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nant Capital, Llc within 3 months outperforms 1 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nant Capital, Llc's insider trading performs compared to the benchmark.
Performance of Nant Capital, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.04 | | | | | |
| Relative Return to S&P 500(%) | 2.46 | | | | | |
Nant Capital, Llc Ownership Network
Nant Capital, Llc Owned Company Details
What does Benitec Biopharma Inc do?
Who are the key executives at Benitec Biopharma Inc?
Nant Capital, Llc is the 10 percent owner of Benitec Biopharma Inc. Other key executives at Benitec Biopharma Inc include director & Executive Director Megan Boston , 10 percent owner Steven Michael Oliveira , and 10 percent owner Patrick Soon-shiong .
Benitec Biopharma Inc (BNTC) Insider Trades Summary
Over the past 18 months, Nant Capital, Llc made no insider transaction in Benitec Biopharma Inc (BNTC). Other recent insider transactions involving Benitec Biopharma Inc (BNTC) include a net purchase of 51,813 shares made by J Kevin Buchi , and a net purchase of 25,907 shares made by Megan Boston .
In summary, during the past 3 months, insiders sold 0 shares of Benitec Biopharma Inc (BNTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Benitec Biopharma Inc (BNTC) were sold and 77,720 shares were bought by its insiders, resulting in a net purchase of 77,720 shares.
Benitec Biopharma Inc (BNTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Benitec Biopharma Inc Insider Transactions
Nant Capital, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Nant Capital, Llc. You might contact Nant Capital, Llc via mailing address: 9922 Jefferson Boulevard, Culver City Ca 90232.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
